-
1
-
-
0031719374
-
Role of drug disposition in drug hypersensitivity: A chemical, molecular, and clinical perspective
-
Park BK, Pirmohamed M, Kitteringham NR. Role of drug disposition in drug hypersensitivity: A chemical, molecular, and clinical perspective. Chem Res Toxicol 1998;11:969-88
-
(1998)
Chem Res Toxicol
, vol.11
, pp. 969-988
-
-
Park, B.K.1
Pirmohamed, M.2
Kitteringham, N.R.3
-
2
-
-
0030731461
-
Mechanism of action of adverse drug reactions: An overview
-
Royer RJ. Mechanism of action of adverse drug reactions: An overview. Pharmacoepidemiol Drug Saf 1997;6:S43-50
-
(1997)
Pharmacoepidemiol Drug Saf
, vol.6
-
-
Royer, R.J.1
-
3
-
-
46249118651
-
Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: Search for signals
-
Suggested a correlation between daily dose of oral medications and the onset of idiosyncratic drug-induced liver injury
-
Lammert C, Einarsson S, Saha C, et al. Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: Search for signals. Hepatology 2008;47:2003-9 Suggested a correlation between daily dose of oral medications and the onset of idiosyncratic drug-induced liver injury.
-
(2008)
Hepatology
, vol.47
, pp. 2003-2009
-
-
Lammert, C.1
Einarsson, S.2
Saha, C.3
-
5
-
-
67651175387
-
Immunological mechanisms in liver injury
-
In: Kaplowitz N, DeLeve L, editors, Marcel Dekker New York
-
Obermayer-Straub P, Manns M. Immunological mechanisms in liver injury. In: Kaplowitz N, DeLeve L, editors. Drug-Induced Liver Disease. Marcel Dekker; New York: 2003. p. 145-9
-
(2003)
Drug-Induced Liver Disease
, pp. 145-149
-
-
Obermayer-Straub, P.1
Manns, M.2
-
6
-
-
0037126649
-
Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States
-
Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947-54
-
(2002)
Ann Intern Med
, vol.137
, pp. 947-954
-
-
Ostapowicz, G.1
Fontana, R.J.2
Schiodt, F.V.3
-
8
-
-
0042744731
-
Drug eruptions: Approaching the diagnosis of drug-induced skin diseases
-
Nigen S, Knowles SR, Shear NH. Drug eruptions: Approaching the diagnosis of drug-induced skin diseases. J Drugs Dermatol 2003;2:278-99
-
(2003)
J Drugs Dermatol
, vol.2
, pp. 278-299
-
-
Nigen, S.1
Knowles, S.R.2
Shear, N.H.3
-
9
-
-
0036570099
-
Timing of new black box warnings and withdrawals for prescription medications
-
Lasser KE, Allen PD, Woolhandler SJ, et al. Timing of new black box warnings and withdrawals for prescription medications. J Am Med Assoc 2002;287:2215-20
-
(2002)
J Am Med Assoc
, vol.287
, pp. 2215-2220
-
-
Lasser, K.E.1
Allen, P.D.2
Woolhandler, S.J.3
-
10
-
-
33747126524
-
Role of animal models in the study of drug-induced hypersensitivity reactions
-
Uetrecht J. Role of animal models in the study of drug-induced hypersensitivity reactions. AAPS J 2006;7:E914-21
-
(2006)
AAPS J.
, vol.7
-
-
Uetrecht, J.1
-
11
-
-
0036154009
-
Underlying endotoxemia augments toxic responses to chlorpromazine is there a relationship to drug idiosyncrasy?
-
Buchweitz JP, Ganey PE, Bursian SJ, Roth RA. Underlying endotoxemia augments toxic responses to chlorpromazine: Is there a relationship to drug idiosyncrasy? J Pharmacol Exp Ther 2002;300:460-7
-
(2002)
J Pharmacol Exp Ther
, vol.300
, pp. 460-467
-
-
Buchweitz, J.P.1
Ganey, P.E.2
Bursian, S.J.3
Roth, R.A.4
-
12
-
-
1642281756
-
Drug-protein adducts: An industry perspective on minimizing the potential for drug bioactivation in drug discovery and development
-
Evans DC, Watt AP, Nicoll-Griffith DA, Baillie TA. Drug-protein adducts: An industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. Chem Res Toxicol 2004;17:3-16
-
(2004)
Chem Res Toxicol
, vol.17
, pp. 3-16
-
-
Evans, D.C.1
Watt, A.P.2
Nicoll-Griffith, D.A.3
Baillie, T.A.4
-
13
-
-
19944399431
-
A comprehensive listing of bioactivation pathways of organic functional groups
-
Provides a thorough overview of RM formation and subsequent toxicities associated with certain 'structural alerts'
-
Kalgutkar AS, Gardner I, Obach RS, et al. A comprehensive listing of bioactivation pathways of organic functional groups. Curr Drug Metab 2005;6:161-225 . Provides a thorough overview of RM formation and subsequent toxicities associated with certain 'structural alerts'.
-
(2005)
Curr Drug Metab
, vol.6
, pp. 161-225
-
-
Kalgutkar, A.S.1
Gardner, I.2
Obach, R.S.3
-
14
-
-
33846820291
-
Progress in QSAR toxicity screening of pharmaceutical impurities and other FDA regulated products
-
Kruhlak NL, Contrera JF, Benz RD, Matthews EJ. Progress in QSAR toxicity screening of pharmaceutical impurities and other FDA regulated products. Adv Drug Deliv Rev 2007;59:43-55
-
(2007)
Adv Drug Deliv Rev
, vol.59
, pp. 43-55
-
-
Kruhlak, N.L.1
Contrera, J.F.2
Benz, R.D.3
Matthews, E.J.4
-
15
-
-
38949104743
-
Idiosyncratic drug reactions: Past, present, and future
-
A concise and perceptive article on the status of IDRs including classic and comtemporary views associated with potential onset mechanisms
-
Uetrecht J. Idiosyncratic drug reactions: Past, present, and future. Chem Res Toxicol 2008;21:84-92 A concise and perceptive article on the status of IDRs including classic and comtemporary views associated with potential onset mechanisms.
-
(2008)
Chem Res Toxicol
, vol.21
, pp. 84-92
-
-
Uetrecht, J.1
-
16
-
-
7444268462
-
Adverse hepatic drug reactions: Inflammatory episodes as consequence and contributor
-
Ganey PE, Luyendyk JP, Maddox JF, Roth RA. Adverse hepatic drug reactions: Inflammatory episodes as consequence and contributor. Chem Biol Interact 2004;150:35-51
-
(2004)
Chem Biol Interact
, vol.150
, pp. 35-51
-
-
Ganey, P.E.1
Luyendyk, J.P.2
Maddox, J.F.3
Roth, R.A.4
-
17
-
-
17644393164
-
Tolerogenic role of Kupffer cells in immune-mediated adverse drug reactions
-
Ju C, Pohl LR. Tolerogenic role of Kupffer cells in immune-mediated adverse drug reactions. Toxicology 2005;209:109-12
-
(2005)
Toxicology
, vol.209
, pp. 109-112
-
-
Ju, C.1
Pohl, L.R.2
-
20
-
-
68949091980
-
Phenotypic characterization of idiosyncratic drug-induced liver injury: The influence of age and sex
-
Lucena MI, Andrade RJ, Kaplowitz N, et al. Phenotypic characterization of idiosyncratic drug-induced liver injury: The influence of age and sex. Hepatology 2009;49:2001-9
-
(2009)
Hepatology
, vol.49
, pp. 2001-2009
-
-
Lucena, M.I.1
Andrade, R.J.2
Kaplowitz, N.3
-
21
-
-
70449103049
-
Genetic association studies in drug-induced liver injury
-
Daly AK, Day CP. Genetic association studies in drug-induced liver injury. Semin Liver Dis 2009;29:400-11
-
(2009)
Semin Liver Dis
, vol.29
, pp. 400-411
-
-
Daly, A.K.1
Day, C.P.2
-
22
-
-
85047694245
-
Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS
-
Fischl MA, Dickinson GM, La Voie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. J Am Med Assoc 1988;259:1185-9
-
(1988)
J Am Med Assoc
, vol.259
, pp. 1185-1189
-
-
Fischl, M.A.1
Dickinson, G.M.2
La Voie, L.3
-
23
-
-
0033014010
-
Factors associated with preventability, predictability, and severity of adverse drug reactions
-
Gholami K, Shalviri G. Factors associated with preventability, predictability, and severity of adverse drug reactions. Ann Pharmacother 1999;33:236-40
-
(1999)
Ann Pharmacother
, vol.33
, pp. 236-240
-
-
Gholami, K.1
Shalviri, G.2
-
24
-
-
34249284163
-
Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury
-
Huang Y, Su W, Huang Y, et al. Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury. J Hepatol 2007;47:128-34
-
(2007)
J Hepatol
, vol.47
, pp. 128-134
-
-
Huang, Y.1
Su, W.2
Huang, Y.3
-
25
-
-
0028270681
-
Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene
-
Lin HJ, Han CY, Lin BK, Hardy S. Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene. Pharmacogenetics 1994;4:125-34
-
(1994)
Pharmacogenetics
, vol.4
, pp. 125-134
-
-
Lin, H.J.1
Han, C.Y.2
Lin, B.K.3
Hardy, S.4
-
27
-
-
33846589652
-
Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury
-
Lang C, Meier Y, Stieger B, et al. Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury. Pharmacogenet Genomics 2007;17:47-60
-
(2007)
Pharmacogenet Genomics
, vol.17
, pp. 47-60
-
-
Lang, C.1
Meier, Y.2
Stieger, B.3
-
28
-
-
0034674901
-
A family of drug transporters: The multidrug resistance-associated proteins
-
Borst P, Evers R, Kool M, Wijnholds J. A family of drug transporters: The multidrug resistance-associated proteins. J Natl Cancer Inst 2000;92:1295-302
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 1295-1302
-
-
Borst, P.1
Evers, R.2
Kool, M.3
Wijnholds, J.4
-
29
-
-
79958047253
-
Risk assessment and mitigation strategies for reactive metabolites in drug discovery and development
-
Thompson RA, Isin EM, Li Y, et al. Risk assessment and mitigation strategies for reactive metabolites in drug discovery and development. Chem Biol Interact 2011;192:65-71
-
(2011)
Chem Biol Interact
, vol.192
, pp. 65-71
-
-
Thompson, R.A.1
Isin, E.M.2
Li, Y.3
-
30
-
-
33845748169
-
Metabolites and safety: What are the concerns, and how should we address them?
-
Smith D, Obach R. Metabolites and safety: What are the concerns, and how should we address them? Chem Res Toxicol 2006;19:1570-9
-
(2006)
Chem Res Toxicol
, vol.19
, pp. 1570-1579
-
-
Smith, D.1
Obach, R.2
-
31
-
-
0028201732
-
Tolerance, danger, and the extended family
-
Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991-1045
-
(1994)
Annu Rev Immunol
, vol.12
, pp. 991-1045
-
-
Matzinger, P.1
-
32
-
-
0028880443
-
Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis
-
Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-7
-
(1995)
N Engl J Med
, vol.333
, pp. 1600-1607
-
-
Roujeau, J.C.1
Kelly, J.P.2
Naldi, L.3
-
33
-
-
0028146935
-
Allergic reactions to parenteral beta-lactam antibiotics in patients with cystic fibrosis
-
Pleasants RA, Walker TR, Samuelson WM. Allergic reactions to parenteral beta-lactam antibiotics in patients with cystic fibrosis. Chest 1994;106:1124-8
-
(1994)
Chest
, vol.106
, pp. 1124-1128
-
-
Pleasants, R.A.1
Walker, T.R.2
Samuelson, W.M.3
-
35
-
-
0036676978
-
Pharmacological interaction of drugs with antigen-specific immune receptors: The p-i concept
-
Pichler WJ. Pharmacological interaction of drugs with antigen-specific immune receptors: The p-i concept. Curr Opin Allergy Clin Immunol 2002;2:301-5
-
(2002)
Curr Opin Allergy Clin Immunol
, vol.2
, pp. 301-305
-
-
Pichler, W.J.1
-
37
-
-
18644372477
-
Structure and stereochemistry of the active metabolite of clopidogrel
-
Pereillo J, Maftouh M, Andrieu A, et al. Structure and stereochemistry of the active metabolite of clopidogrel. Drug Metab Dispos 2002;30:1288-95
-
(2002)
Drug Metab Dispos
, vol.30
, pp. 1288-1295
-
-
Pereillo, J.1
Maftouh, M.2
Andrieu, A.3
-
38
-
-
0021995797
-
Disposition and metabolic fate of 14C-quazepam in man
-
Zampaglione N, Hilbert J, Ning J, et al. Disposition and metabolic fate of 14C-quazepam in man. Drug Metab Dispos 1985;13:25-9
-
(1985)
Drug Metab Dispos
, vol.13
, pp. 25-29
-
-
Zampaglione, N.1
Hilbert, J.2
Ning, J.3
-
40
-
-
0024345539
-
Subcellular binding and effects on calcium homeostasis produced by acetaminophen and a nonhepatotoxic regioisomer, 3'-hydroxyacetanilide, in mouse liver
-
Tirmenstein MA, Nelson SD. Subcellular binding and effects on calcium homeostasis produced by acetaminophen and a nonhepatotoxic regioisomer, 3'-hydroxyacetanilide, in mouse liver. J Biol Chem 1989;264:9814-19
-
(1989)
J Biol Chem
, vol.264
, pp. 9814-9819
-
-
Tirmenstein, M.A.1
Nelson, S.D.2
-
41
-
-
33947204690
-
Mitochondrial abnormalities-A link to idiosyncratic drug hepatotoxicity?
-
Boelsterli UA, Lim PLK. Mitochondrial abnormalities-a link to idiosyncratic drug hepatotoxicity? Toxicol Appl Pharmacol 2007;220:92-107
-
(2007)
Toxicol Appl Pharmacol
, vol.220
, pp. 92-107
-
-
Boelsterli, U.A.1
Lim, P.L.K.2
-
42
-
-
69049104063
-
Functional and toxicological consequences of metabolic bioactivation of methapyrilene via thiophene Soxidation: Induction of cell defence, apoptosis and hepatic necrosis
-
Mercer AE, Regan SL, Hirst CM, et al. Functional and toxicological consequences of metabolic bioactivation of methapyrilene via thiophene Soxidation: Induction of cell defence, apoptosis and hepatic necrosis. Toxicol Appl Pharmacol 2009;239:297-305
-
(2009)
Toxicol Appl Pharmacol
, vol.239
, pp. 297-305
-
-
Mercer, A.E.1
Regan, S.L.2
Hirst, C.M.3
-
43
-
-
0021083310
-
Drug protein conjugates-VI Role of glutathione in the metabolism of captopril and captopril plasma protein conjugates
-
Yeung JH, Breckenridge AM, Park BK. Drug protein conjugates-VI. Role of glutathione in the metabolism of captopril and captopril plasma protein conjugates. Biochem Pharmacol 1983;32:3619-25
-
(1983)
Biochem Pharmacol
, vol.32
, pp. 3619-3625
-
-
Yeung, J.H.1
Breckenridge, A.M.2
Park, B.K.3
-
44
-
-
0018975497
-
The captopril-induced eruption. A possible mechanism: Cutaneous kinin potentiation
-
Wilkin JK, Hammond JJ, Kirkendall WM. The captopril-induced eruption. A possible mechanism: Cutaneous kinin potentiation. Arch Dermatol 1980;116:902-5
-
(1980)
Arch Dermatol
, vol.116
, pp. 902-905
-
-
Wilkin, J.K.1
Hammond, J.J.2
Kirkendall, W.M.3
-
46
-
-
0021044608
-
Low-dose captopril for the treatment of mild to moderate hypertension
-
Freis ED, Materson J, Neal WW. Low-dose captopril for the treatment of mild to moderate hypertension. Hypertension 1983;5:III.
-
(1983)
Hypertension
, vol.5
, pp. 3
-
-
Freis, E.D.1
Materson, J.2
Neal, W.W.3
-
47
-
-
0022623898
-
The disposition and metabolism of captopril
-
Drummer OH, Jarrott B. The disposition and metabolism of captopril. Med Res Rev 1986;6:75-97
-
(1986)
Med Res Rev
, vol.6
, pp. 75-97
-
-
Drummer, O.H.1
Jarrott, B.2
-
48
-
-
0016167068
-
Treatment of chronic urticaria with a proteinase (kallikrein) inhibitor
-
Berova N, Petkov I, Andreev VC. Treatment of chronic urticaria with a proteinase (kallikrein) inhibitor. Br J Dermatol 1974;90:431-4
-
(1974)
Br J Dermatol
, vol.90
, pp. 431-434
-
-
Berova, N.1
Petkov, I.2
Andreev, V.C.3
-
50
-
-
0025246199
-
Sulfhydryl drug-induced eruption: A clinical and histological study
-
Kitamura K, Aihara M, Osawa J, et al. Sulfhydryl drug-induced eruption: A clinical and histological study. J Dermatol 1990;17:44-51
-
(1990)
J Dermatol
, vol.17
, pp. 44-51
-
-
Kitamura, K.1
Aihara, M.2
Osawa, J.3
-
51
-
-
0026087437
-
Drug-induced pemphigus: Autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril-induced pemphigus
-
Korman NJ, Eyre RW, Zone J, Stanley JR. Drug-induced pemphigus: Autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril-induced pemphigus. J Invest Dermatol 1991;96:273-6
-
(1991)
J Invest Dermatol
, vol.96
, pp. 273-276
-
-
Korman, N.J.1
Eyre, R.W.2
Zone, J.3
Stanley, J.R.4
-
53
-
-
0022570998
-
Adverse effects profile of sulfhydryl compounds in man
-
Jaffe IA. Adverse effects profile of sulfhydryl compounds in man. Am J Med 1986;80:471-6
-
(1986)
Am J Med
, vol.80
, pp. 471-476
-
-
Jaffe, I.A.1
-
54
-
-
0023060592
-
Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril
-
Irvin JD, Viau JM. Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril. Am J Med 1986;81:46-50
-
(1986)
Am J Med
, vol.81
, pp. 46-50
-
-
Irvin, J.D.1
Viau, J.M.2
-
55
-
-
80053004364
-
Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: A perspective based on the critical examination of trends in the top 200 drugs marketed in the United States
-
An up-to-date review of the impact of structural alerts, RM formation, underlying mechanisms of toxicity and potential strategies for reducing the incidence of IDRs
-
Stepan AF, Walker DP, Bauman J, et al. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: A perspective based on the critical examination of trends in the top 200 drugs marketed in the United States. Chem Res Toxicol 2011;24:1345-410 . An up-to-date review of the impact of structural alerts, RM formation, underlying mechanisms of toxicity and potential strategies for reducing the incidence of IDRs.
-
(2011)
Chem Res Toxicol
, vol.24
, pp. 1345-1410
-
-
Stepan, A.F.1
Walker, D.P.2
Bauman, J.3
-
56
-
-
0035832506
-
Lessons from the glitazones: A story of drug development
-
Gale EAM. Lessons from the glitazones: A story of drug development. Lancet 2001;357:1870-5
-
(2001)
Lancet
, vol.357
, pp. 1870-1875
-
-
Gale, E.A.M.1
-
57
-
-
0032568261
-
Hepatic dysfunction associated with troglitazone [1]
-
Watkins PB, Whitcomb RW. Hepatic dysfunction associated with troglitazone [1]. N Engl J Med 1998;338:916-17
-
(1998)
N Engl J Med
, vol.338
, pp. 916-917
-
-
Watkins, P.B.1
Whitcomb, R.W.2
-
59
-
-
0037058254
-
Differential in vitro hepatotoxicity of troglitazone and rosiglitazone among cryopreserved human hepatocytes from 37 donors
-
Lloyd S, Hayden MJ, Sakai Y, et al. Differential in vitro hepatotoxicity of troglitazone and rosiglitazone among cryopreserved human hepatocytes from 37 donors. Chem Biol Interact 2002;142:57-71
-
(2002)
Chem Biol Interact
, vol.142
, pp. 57-71
-
-
Lloyd, S.1
Hayden, M.J.2
Sakai, Y.3
-
60
-
-
33748656068
-
Thiazolidinedione bioactivation: A comparison of the bioactivation potentials of troglitazone, rosiglitazone, and pioglitazone using stable isotope-labeled analogues and liquid chromatography tandem mass spectrometry
-
Alvarez-Sanchez R, Montavon F, Hartung T, Pahler A. Thiazolidinedione bioactivation: A comparison of the bioactivation potentials of troglitazone, rosiglitazone, and pioglitazone using stable isotope-labeled analogues and liquid chromatography tandem mass spectrometry. Chem Res Toxicol 2006;19:1106-16
-
(2006)
Chem Res Toxicol
, vol.19
, pp. 1106-1116
-
-
Alvarez-Sanchez, R.1
Montavon, F.2
Hartung, T.3
Pahler, A.4
-
61
-
-
17744394481
-
Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission
-
Kassahun K, Pearson PG, Tang W, et al. Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission. Chem Res Toxicol 2001;14:62-70
-
(2001)
Chem Res Toxicol
, vol.14
, pp. 62-70
-
-
Kassahun, K.1
Pearson, P.G.2
Tang, W.3
-
62
-
-
0032725398
-
Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver microsomes
-
Yamazaki H, Shibata A, Suzuki M, et al. Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver microsomes. Drug Metab Dispos 1999;27:1260-6
-
(1999)
Drug Metab Dispos
, vol.27
, pp. 1260-1266
-
-
Yamazaki, H.1
Shibata, A.2
Suzuki, M.3
-
63
-
-
0037379266
-
Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition
-
Sahi J, Black CB, Hamilton GA, et al. Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition. Drug Metab Dispos 2003;31:439-46
-
(2003)
Drug Metab Dispos
, vol.31
, pp. 439-446
-
-
Sahi, J.1
Black, C.B.2
Hamilton, G.A.3
-
64
-
-
0032169485
-
The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions
-
Lehmann JM, McKee DD, Watson MA, et al. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 1998;102:1016-23
-
(1998)
J Clin Invest
, vol.102
, pp. 1016-1023
-
-
Lehmann, J.M.1
McKee, D.D.2
Watson, M.A.3
-
65
-
-
0036528233
-
PXR, car and drug metabolism
-
Illustrates the importance of these transcription factors in sensing and modulating xenobiotic metabolism, which could in turn impact the onset of DDIs
-
Willson TM, Kliewer SA. PXR, car and drug metabolism. Nat Rev Drug Discov 2002;1:259-66 Illustrates the importance of these transcription factors in sensing and modulating xenobiotic metabolism, which could in turn impact the onset of DDIs.
-
(2002)
Nat Rev Drug Discov
, vol.1
, pp. 259-266
-
-
Willson, T.M.1
Kliewer, S.A.2
-
66
-
-
0036320382
-
Phenol sulfotransferase, ST1A3, as the main enzyme catalyzing sulfation of troglitazone in human liver
-
Honma W, Shimada M, Sasano H, et al. Phenol sulfotransferase, ST1A3, as the main enzyme catalyzing sulfation of troglitazone in human liver. Drug Metab Dispos 2002;30:944-9
-
(2002)
Drug Metab Dispos
, vol.30
, pp. 944-949
-
-
Honma, W.1
Shimada, M.2
Sasano, H.3
-
67
-
-
2442707819
-
Metabolic activation of troglitazone: Identification of a reactive metabolite and mechanisms involved
-
He K, Talaat RE, Pool WF, et al. Metabolic activation of troglitazone: Identification of a reactive metabolite and mechanisms involved. Drug Metab Dispos 2004;32:639-46
-
(2004)
Drug Metab Dispos
, vol.32
, pp. 639-646
-
-
He, K.1
Talaat, R.E.2
Pool, W.F.3
-
68
-
-
27444439653
-
Detection of autoantibody to aldolase B in sera from patients with troglitazone-induced liver dysfunction
-
Maniratanachote R, Shibata A, Kaneko S, et al. Detection of autoantibody to aldolase B in sera from patients with troglitazone-induced liver dysfunction. Toxicology 2005;216:15-23
-
(2005)
Toxicology
, vol.216
, pp. 15-23
-
-
Maniratanachote, R.1
Shibata, A.2
Kaneko, S.3
-
69
-
-
0038650658
-
Mechanisms of troglitazone hepatotoxicity
-
Smith MT. Mechanisms of troglitazone hepatotoxicity. Chem Res Toxicol 2003;16:679-87
-
(2003)
Chem Res Toxicol
, vol.16
, pp. 679-687
-
-
Smith, M.T.1
-
70
-
-
0035120396
-
A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis
-
Caldwell SH, Hespenheide EE, Redick JA, et al. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis. Am J Gastroenterol 2001;96:519-25
-
(2001)
Am J Gastroenterol
, vol.96
, pp. 519-525
-
-
Caldwell, S.H.1
Hespenheide, E.E.2
Redick, J.A.3
-
71
-
-
34347250517
-
Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities
-
Ong MMK, Latchoumycandane C, Boelsterli UA. Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities. Toxicol Sci 2007;97:205-13
-
(2007)
Toxicol Sci
, vol.97
, pp. 205-213
-
-
Ong, M.M.K.1
Latchoumycandane, C.2
Boelsterli, U.A.3
-
72
-
-
34347236533
-
Troglitazone hepatotoxicity: Are we getting closer to understanding idiosyncratic liver injury?
-
Jaeschke H. Troglitazone hepatotoxicity: Are we getting closer to understanding idiosyncratic liver injury? Toxicol Sci 2007;97:1-3
-
(2007)
Toxicol Sci
, vol.97
, pp. 1-3
-
-
Jaeschke, H.1
-
74
-
-
0017118316
-
Renal effects of SKF 62698 (SKF): A new uricosuric diuretic
-
Lau K, Goldberg M, Stote R, Agus ZS. Renal effects of SKF 62698 (SKF): A new uricosuric diuretic. Clin Res 1976;24
-
(1976)
Clin Res
, vol.24
-
-
Lau, K.1
Goldberg, M.2
Stote, R.3
Agus, Z.S.4
-
76
-
-
0024523867
-
Immune mechanisms in tienilic acid associated hepatotoxicity
-
Neuberger J, Williams R. Immune mechanisms in tienilic acid associated hepatotoxicity. Gut 1989;30:515-19
-
(1989)
Gut
, vol.30
, pp. 515-519
-
-
Neuberger, J.1
Williams, R.2
-
77
-
-
0021278268
-
Metabolic hydroxylation of the thiophene ring: Isolation of 5-hydroxy-tienilic acid as the major urinary metabolite of tienilic acid in man and rat
-
Mansuy D, Dansette PM, Foures C. Metabolic hydroxylation of the thiophene ring: Isolation of 5-hydroxy-tienilic acid as the major urinary metabolite of tienilic acid in man and rat. Biochem Pharmacol 1984;33:1429-35
-
(1984)
Biochem Pharmacol
, vol.33
, pp. 1429-1435
-
-
Mansuy, D.1
Dansette, P.M.2
Foures, C.3
-
78
-
-
0033596707
-
Electrospray ionization mass spectrometric analysis of intact cytochrome P450: Identification of tienilic acid adducts to P450 2C9
-
Koenigs LL, Peter RM, Hunter AP, et al. Electrospray ionization mass spectrometric analysis of intact cytochrome P450: Identification of tienilic acid adducts to P450 2C9. Biochemistry 1999;38:2312-19
-
(1999)
Biochemistry
, vol.38
, pp. 2312-2319
-
-
Koenigs, L.L.1
Peter, R.M.2
Hunter, A.P.3
-
79
-
-
0021355271
-
A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis
-
Homberg JC, Andre C, Abuaf N. A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis. Clin Exp Immunol 1984;55:561-70
-
(1984)
Clin Exp Immunol
, vol.55
, pp. 561-570
-
-
Homberg, J.C.1
Andre, C.2
Abuaf, N.3
-
80
-
-
0028078626
-
Thiophene derivatives as new mechanism-based inhibitors of cytochromes P-450: Inactivation of yeast-expressed human liver cytochrome P-450 2C9 by tienilic acid
-
Lopez-Garcia M, Dansette P, Mansuy D. Thiophene derivatives as new mechanism-based inhibitors of cytochromes P-450: Inactivation of yeast-expressed human liver cytochrome P-450 2C9 by tienilic acid. Biochemistry 1994;33:166-75
-
(1994)
Biochemistry
, vol.33
, pp. 166-1675
-
-
Lopez-Garcia, M.1
Dansette, P.2
Mansuy, D.3
-
81
-
-
52049083469
-
The crucial protective role of glutathione against tienilic acid hepatotoxicity in rats
-
Nishiya T, Mori K, Hattori C, et al. The crucial protective role of glutathione against tienilic acid hepatotoxicity in rats. Toxicol Appl Pharmacol 2008;232:280-91
-
(2008)
Toxicol Appl Pharmacol
, vol.232
, pp. 280-291
-
-
Nishiya, T.1
Mori, K.2
Hattori, C.3
-
82
-
-
38149106764
-
Irreversible alkylation of human serum albumin by zileuton metabolite 2-acetylbenzothiophene-Soxide: A potential model for hepatotoxicity
-
Li F, Chordia MD, Woodling KA, Macdonald TL. Irreversible alkylation of human serum albumin by zileuton metabolite 2-acetylbenzothiophene-Soxide: A potential model for hepatotoxicity. Chem Res Toxicol 2007;20:1854-61
-
(2007)
Chem Res Toxicol
, vol.20
, pp. 1854-1861
-
-
Li, F.1
Chordia, M.D.2
Woodling, K.A.3
Macdonald, T.L.4
-
83
-
-
0029915834
-
Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial
-
Zileuton Clinical Trial Group
-
Israel E, Cohn J, Dube L, Drazen JM. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group. JAMA 1996;275:931-6
-
(1996)
JAMA
, vol.275
, pp. 931-936
-
-
Israel, E.1
Cohn, J.2
Dube, L.3
Drazen, J.M.4
-
84
-
-
0029853741
-
Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: A 6- month randomized multicenter trial
-
Liu MC, Dube LM, Lancaster J, et al. Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: A 6- month randomized multicenter trial. J Allergy Clin Immunol 1996;98:859-71
-
(1996)
J Allergy Clin Immunol
, vol.98
, pp. 859-871
-
-
Liu, M.C.1
Dube, L.M.2
Lancaster, J.3
-
85
-
-
0031927443
-
Safety and clinical efficacy of zileuton in patients with chronic asthma
-
Lazarus SC, Lee T, Kemp JP, et al. Safety and clinical efficacy of zileuton in patients with chronic asthma. Am J Manag Care 1998;4:841-8
-
(1998)
Am J Manag Care
, vol.4
, pp. 841-848
-
-
Lazarus, S.C.1
Lee, T.2
Kemp, J.P.3
-
86
-
-
34547956818
-
Efficacy of zileuton controlled-release tablets administered twice daily in the treatment of moderate persistent asthma: A 3-month randomized controlled study
-
Nelson H, Kemp J, Berger W, et al. Efficacy of zileuton controlled-release tablets administered twice daily in the treatment of moderate persistent asthma: A 3-month randomized controlled study. Ann Allergy Asthma Immunol 2007;99:178-84
-
(2007)
Ann Allergy Asthma Immunol
, vol.99
, pp. 178-184
-
-
Nelson, H.1
Kemp, J.2
Berger, W.3
-
87
-
-
34249747837
-
The safety and efficacy of zileuton controlled-release tablets as adjunctive therapy to usual care in the treatment of moderate persistent asthma: A 6-month randomized controlled study
-
Wenzel S, Busse W, Calhoun W, et al. The safety and efficacy of zileuton controlled-release tablets as adjunctive therapy to usual care in the treatment of moderate persistent asthma: A 6-month randomized controlled study. J Asthma 2007;44:305-10
-
(2007)
J Asthma
, vol.44
, pp. 305-310
-
-
Wenzel, S.1
Busse, W.2
Calhoun, W.3
-
88
-
-
34548311561
-
Clinical pattern of zileuton-associated liver injury: Results of a 12-month study in patients with chronic asthma
-
Watkins PB, Dube LM, Walton-Bowen K, et al. Clinical pattern of zileuton-associated liver injury: Results of a 12-month study in patients with chronic asthma. Drug Saf 2007;30:805-15
-
(2007)
Drug Saf
, vol.30
, pp. 805-815
-
-
Watkins, P.B.1
Dube, L.M.2
Walton-Bowen, K.3
-
89
-
-
0036127307
-
Biotransformation reactions of five-membered aromatic heterocyclic rings
-
Dalvie DK, Kalgutkar AS, Khojasteh-Bakht SC, et al. Biotransformation reactions of five-membered aromatic heterocyclic rings. Chem Res Toxicol 2002;15:269-99
-
(2002)
Chem Res Toxicol
, vol.15
, pp. 269-299
-
-
Dalvie, D.K.1
Kalgutkar, A.S.2
Khojasteh-Bakht, S.C.3
-
90
-
-
0030911121
-
Molecular structure and hepatotoxicity: Compared data about two closely related thiophene compounds
-
Mansuy D. Molecular structure and hepatotoxicity: Compared data about two closely related thiophene compounds. J Hepatol Suppl 1997;26:22-5
-
(1997)
J Hepatol Suppl
, vol.26
, pp. 22-25
-
-
Mansuy, D.1
-
91
-
-
0028785979
-
Identification of the human liver cytochrome P450 enzymes involved in the metabolism of zileuton (ABT-077) and its N-dehydroxylated metabolite, Abbott- 66193
-
Machinist JM, Mayer MD, Shet MS, et al. Identification of the human liver cytochrome P450 enzymes involved in the metabolism of zileuton (ABT-077) and its N-dehydroxylated metabolite, Abbott- 66193. Drug Metab Dispos 1995;23:1163-74
-
(1995)
Drug Metab Dispos
, vol.23
, pp. 1163-1174
-
-
Machinist, J.M.1
Mayer, M.D.2
Shet, M.S.3
-
92
-
-
0026441179
-
Kinetics and mechanism of degradation of Zileuton, a potent 5-lipoxygenase inhibitor
-
Alvarez FJ, Slade RT. Kinetics and mechanism of degradation of Zileuton, a potent 5-lipoxygenase inhibitor. Pharm Res 1992;9:1465-73
-
(1992)
Pharm Res
, vol.9
, pp. 1465-1473
-
-
Alvarez, F.J.1
Slade, R.T.2
-
93
-
-
1342310597
-
In Vitro Metabolism of 2-Acetylbenzothiophene: Relevance to Zileuton Hepatotoxicity
-
Joshi EM, Heasley BH, Chordia MD, Macdonald TL. In Vitro Metabolism of 2-Acetylbenzothiophene: Relevance to Zileuton Hepatotoxicity. Chem Res Toxicol 2004;17:137-43
-
(2004)
Chem Res Toxicol
, vol.17
, pp. 137-143
-
-
Joshi, E.M.1
Heasley, B.H.2
Chordia, M.D.3
Macdonald, T.L.4
-
95
-
-
0032946198
-
Metabolism-dependent hepatotoxicity of methimazole in mice depleted of glutathione
-
Mizutani T, Murakami M, Shirai M, et al. Metabolism-dependent hepatotoxicity of methimazole in mice depleted of glutathione. J Appl Toxicol 1999;19:193-8
-
(1999)
J Appl Toxicol
, vol.19
, pp. 193-198
-
-
Mizutani, T.1
Murakami, M.2
Shirai, M.3
-
96
-
-
0016259426
-
S oxidation of thioureylenes catalyzed by a microsomal flavoprotein mixed function oxidase
-
Poulsen LL, Hyslop RM, Ziegler DM. S oxidation of thioureylenes catalyzed by a microsomal flavoprotein mixed function oxidase. Biochem Pharmacol 1974;23:3431-40
-
(1974)
Biochem Pharmacol
, vol.23
, pp. 3431-3440
-
-
Poulsen, L.L.1
Hyslop, R.M.2
Ziegler, D.M.3
-
97
-
-
0034122751
-
Evidence for the involvement of N-methylthiourea, a ring cleavage metabolite, in the hepatotoxicity of methimazole in glutathione-depleted mice: Structure-toxicity and metabolic studies
-
Mizutani T, Yoshida K, Murakami M, et al. Evidence for the involvement of N-methylthiourea, a ring cleavage metabolite, in the hepatotoxicity of methimazole in glutathione-depleted mice: Structure-toxicity and metabolic studies. Chem Res Toxicol 2000;13:170-6
-
(2000)
Chem Res Toxicol
, vol.13
, pp. 170-176
-
-
Mizutani, T.1
Yoshida, K.2
Murakami, M.3
-
99
-
-
0015385513
-
Sudoxicam and related N-heterocyclic carboxamides of 4-hydroxy-2H- 1,2-benzothiazine 1,1-dioxide. Potent nonsteroidal antiinflammatory agents
-
Lombardino JG, Wiseman EH. Sudoxicam and related N-heterocyclic carboxamides of 4-hydroxy-2H- 1,2-benzothiazine 1,1-dioxide. Potent nonsteroidal antiinflammatory agents. J Med Chem 1972;15:848-9
-
(1972)
J Med Chem
, vol.15
, pp. 848-849
-
-
Lombardino, J.G.1
Wiseman, E.H.2
-
100
-
-
18144384396
-
Nonsteroidal anti-inflammatory drugs and hepatic toxicity: A systematic review of randomized controlled trials in arthritis patients
-
Rostom A, Goldkind L, Laine L. Nonsteroidal anti-inflammatory drugs and hepatic toxicity: A systematic review of randomized controlled trials in arthritis patients. Clin Gastroenterol Hepatol 2005;3:489-98
-
(2005)
Clin Gastroenterol Hepatol
, vol.3
, pp. 489-498
-
-
Rostom, A.1
Goldkind, L.2
Laine, L.3
-
101
-
-
53549107196
-
In vitro metabolism and covalent binding of enol-carboxamide derivatives and anti-inflammatory agents sudoxicam and meloxicam: Insights into the hepatotoxicity of sudoxicam
-
Obach RS, Kalgutkar AS, Ryder TF, Walker GS. In vitro metabolism and covalent binding of enol-carboxamide derivatives and anti-inflammatory agents sudoxicam and meloxicam: Insights into the hepatotoxicity of sudoxicam. Chem Res Toxicol 2008;21:1890-9
-
(2008)
Chem Res Toxicol
, vol.21
, pp. 1890-1899
-
-
Obach, R.S.1
Kalgutkar, A.S.2
Ryder, T.F.3
Walker, G.S.4
-
102
-
-
67349272258
-
Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity
-
Cosgrove BD, King BM, Hasan MA, et al. Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity. Toxicol Appl Pharmacol 2009;237:317-30
-
(2009)
Toxicol Appl Pharmacol
, vol.237
, pp. 317-330
-
-
Cosgrove, B.D.1
King, B.M.2
Hasan, M.A.3
-
103
-
-
75749102996
-
Review: Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans
-
Farid NA, Kurihara A, Wrighton SA. Review: Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans. J Clin Pharmacol 2010;50:126-42
-
(2010)
J Clin Pharmacol
, vol.50
, pp. 126-142
-
-
Farid, N.A.1
Kurihara, A.2
Wrighton, S.A.3
-
104
-
-
34548473336
-
The direct thrombin inhibitor ximelagatran/melagatran: A systematic review on clinical applications and an evidence based assessment of risk benefit profile
-
Testa L, Bhindi R, Agostoni P, et al. The direct thrombin inhibitor ximelagatran/melagatran: A systematic review on clinical applications and an evidence based assessment of risk benefit profile. Expert Opin Drug Saf 2007;6:397-406
-
(2007)
Expert Opin Drug Saf
, vol.6
, pp. 397-406
-
-
Testa, L.1
Bhindi, R.2
Agostoni, P.3
-
105
-
-
77955676570
-
Characterization of glutathione conjugates of duloxetine by mass spectrometry and evaluation of in silico approaches to rationalize the site of conjugation for thiophene containing drugs
-
Wu G, Vashishtha SC, Erve JCL. Characterization of glutathione conjugates of duloxetine by mass spectrometry and evaluation of in silico approaches to rationalize the site of conjugation for thiophene containing drugs. Chem Res Toxicol 2010;23:1393-404
-
(2010)
Chem Res Toxicol
, vol.23
, pp. 1393-1404
-
-
Wu, G.1
Vashishtha, S.C.2
Erve, J.C.L.3
-
106
-
-
66149104042
-
In vitro screening of 50 highly prescribed drugs for thiol adduct formation - Comparison of potential for drug-induced toxicity and extent of adduct formation
-
Gan J, Ruan Q, He B, et al. In vitro screening of 50 highly prescribed drugs for thiol adduct formation - Comparison of potential for drug-induced toxicity and extent of adduct formation. Chem Res Toxicol 2009;22:690-8
-
(2009)
Chem Res Toxicol
, vol.22
, pp. 690-698
-
-
Gan, J.1
Ruan, Q.2
He, B.3
-
107
-
-
4544363071
-
Liver transplantation for acute liver failure from drug induced liver injury in the United States
-
Russo MW, Galanko JA, Shrestha R, et al. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl 2004;10:1018-23
-
(2004)
Liver Transpl
, vol.10
, pp. 1018-1023
-
-
Russo, M.W.1
Galanko, J.A.2
Shrestha, R.3
-
108
-
-
18844373318
-
Role of metabolism in drug-induced idiosyncratic hepatotoxicity
-
Highlights the importance of drug dose and total daily body burden associated with onset of idiosyncratic liver toxicity
-
Walgren JL, Mitchell MD, Thompson DC. Role of metabolism in drug-induced idiosyncratic hepatotoxicity. Crit Rev Toxicol 2005;35:325-61 Highlights the importance of drug dose and total daily body burden associated with onset of idiosyncratic liver toxicity.
-
(2005)
Crit Rev Toxicol
, vol.35
, pp. 325-361
-
-
Walgren, J.L.1
Mitchell, M.D.2
Thompson, D.C.3
-
109
-
-
17944393027
-
The danger hypothesis applied to idiosyncratic drug reactions
-
Seguin B, Uetrecht J. The danger hypothesis applied to idiosyncratic drug reactions. Curr Opin Allergy Clin Immunol 2003;3:235-42
-
(2003)
Curr Opin Allergy Clin Immunol
, vol.3
, pp. 235-242
-
-
Seguin, B.1
Uetrecht, J.2
-
110
-
-
0029988450
-
Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: Clinical syndromes and pathogenesis
-
Cribb AE, Lee BL, Trepanier LA, Spielberg SP. Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: Clinical syndromes and pathogenesis. Adverse Drug React Toxicol Rev 1996;15:9-50
-
(1996)
Adverse Drug React Toxicol Rev
, vol.15
, pp. 9-50
-
-
Cribb, A.E.1
Lee, B.L.2
Trepanier, L.A.3
Spielberg, S.P.4
-
111
-
-
0033491134
-
Diagnosis of allergic reactions to sulfonamides
-
Gruchalla RS. Diagnosis of allergic reactions to sulfonamides. Allergy 1999;54(Suppl 58):28-32
-
(1999)
Allergy
, vol.54
, Issue.SUPPL. 58
, pp. 28-32
-
-
Gruchalla, R.S.1
-
112
-
-
78649231563
-
Challenges and solutions to metabolites in safety testing: Impact of the International Conference on Harmonization M3(R2) guidance
-
Proposes a strategy for streamlining the process outlined the ICH M3 R2) guidance and discusses the use of novel technologies to improve the detection of stable RMs
-
Yu H, Bischoff D, Tweedie D. Challenges and solutions to metabolites in safety testing: Impact of the International Conference on Harmonization M3(R2) guidance. Expert Opin Drug Metab Toxicol 2010;6:1539-49 Proposes a strategy for streamlining the process outlined the ICH M3 (R2) guidance and discusses the use of novel technologies to improve the detection of stable RMs.
-
(2010)
Expert Opin Drug Metab Toxicol
, vol.6
, pp. 1539-1549
-
-
Yu, H.1
Bischoff, D.2
Tweedie, D.3
|